Year |
Citation |
Score |
2020 |
Khanna S, Palackdharry S, Roof L, Wicker CA, Mark J, Zhu Z, Jandorav R, Molinolo A, Takiar V, Wise-Draper TM. Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer. Cancers of the Head & Neck. 5: 11. PMID 32944296 DOI: 10.1186/S41199-020-00058-2 |
0.345 |
|
2020 |
Wicker CA, Takiar V, Suganya R, Arnold SM, Brill YM, Chen L, Horbinski CM, Napier D, Valentino J, Kudrimoti MR, Yu G, Izumi T. Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients. Oral Oncology. 111: 104949. PMID 32801084 DOI: 10.1016/J.Oraloncology.2020.104949 |
0.37 |
|
2020 |
Lewis LM, Tang AL, Wise-Draper TM, Myers KC, Greenberger JS, Takiar V. Successful use of a therapeutic trial of graduated volume and dose escalation for postoperative head and neck radiotherapy in a Fanconi anemia patient. Head & Neck. PMID 32770810 DOI: 10.1002/Hed.26395 |
0.416 |
|
2020 |
Havard M, Esslinger H, Mierzwa M, Kharofa J, Takiar V. Increased Pain Reporting by Head and Neck Cancer Patients at Radiation Oncology Consultation: A Quality-of-Life Analysis. The Laryngoscope. PMID 32609888 DOI: 10.1002/Lary.28784 |
0.345 |
|
2020 |
Leddon J, Chirra M, Agrawal A, Roof L, Trotier D, Shaikh H, Stone T, Jandarov R, Takiar V, Wise-Draper TM. Incidence of hypothyroidism in head and neck squamous cell carcinoma patients receiving radiotherapy with and without immune checkpoint inhibitors. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E18551 |
0.38 |
|
2020 |
Gulati S, Haque S, Palackdharry S, Steele A, Allen C, Takiar V, Riaz MK, Lehn M, Jandarov R, Zender C, Patil Y, Tang AL, Cervenka B, Sukari A, Nagasaka M, et al. Single-cell multiplexed proteomics to identify novel polyfunctional CD8+ T cell signatures induced by nivolumab in head and neck cancer patients after salvage surgery. Journal of Clinical Oncology. 38: 6576-6576. DOI: 10.1200/Jco.2020.38.15_Suppl.6576 |
0.322 |
|
2020 |
Hunt BG, Wicker CA, Bourn J, Lower E, Takiar V, Waltz SE. Abstract A32: Targeting RON-mediated metabolic vulnerabilities in recurrent/progressive breast cancer Cancer Research. 80. DOI: 10.1158/1538-7445.Camodels2020-A32 |
0.312 |
|
2020 |
Wicker CA, Hunt BG, Palackdharry S, Elaban WR, Mills GB, Wise-Draper T, Waltz S, Takiar V. Abstract 6278: Glutaminase inhibition in combination with ionizing radiation improves treatment response in head and neck squamous cell carcinoma models Cancer Research. 80: 6278-6278. DOI: 10.1158/1538-7445.Am2020-6278 |
0.412 |
|
2020 |
Weatherford L, Kuhnell D, Palackdharry S, Vachon R, Takiar V, Langevin S, Wise-Draper T. LSD1 Inhibitor and Cisplatin Combination Treatment of Sinonasal Squamous Cell Carcinoma Cell Lines International Journal of Radiation Oncology Biology Physics. 106: 1189. DOI: 10.1016/J.Ijrobp.2019.11.128 |
0.326 |
|
2019 |
Gulati S, Desai J, Palackdharry SM, Morris JC, Zhu Z, Jandarov R, Riaz MK, Takiar V, Mierzwa M, Gutkind JS, Molinolo A, Desai PB, Sadraei NH, Wise-Draper TM. Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer. Cancer. PMID 31626727 DOI: 10.1002/Cncr.32539 |
0.409 |
|
2019 |
Haque S, Karivedu V, Riaz MK, Choi D, Roof L, Hassan SZ, Zhu Z, Jandarov R, Takiar V, Tang A, Wise-Draper T. High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma. Oral Oncology. 88: 9-15. PMID 30616803 DOI: 10.1016/J.Oraloncology.2018.11.010 |
0.397 |
|
2019 |
Karivedu V, Yaniv B, Asman M, Palackdharry S, Gulati S, Jandarov R, Sadraei NH, Takiar V, Wise-Draper TM. Metformin treatment of locally advanced head and neck squamous cell carcinoma (LAHNSCC) patients induces an anti-tumorigenic immune response. Journal of Clinical Oncology. 37: 6037-6037. DOI: 10.1200/Jco.2019.37.15_Suppl.6037 |
0.392 |
|
2019 |
Moreno AC, Wilke C, Wang H, Tung SS, Pollard C, Garden AS, Morrison WH, Rosenthal DI, Fuller CD, Gunn GB, Reddy JP, Shah SJ, Frank SJ, Takiar V, Phan J. Optimizing laryngeal sparing with intensity modulated radiotherapy or volumetric modulated arc therapy for unilateral tonsil cancer Physics and Imaging in Radiation Oncology. 10: 29-34. DOI: 10.1016/J.Phro.2019.04.002 |
0.367 |
|
2019 |
Awan M, Gittleman H, Barnholtz-Sloan J, Machtay M, Nguyen-Tan P, Rosenthal D, Takiar V, Garden A, Thorstad W, Wong S, Trotti A, Bonner J, Ridge J, Shenouda G, Suntharalingam M, et al. A Nomogram for Outcomes after Chemoradiation for Non-HPV-Related Squamous Cell Carcinomas of the Head and Neck – A Pooled Analysis of NRG Oncology RTOG 0129 and 0522 International Journal of Radiation Oncology*Biology*Physics. 105: E371. DOI: 10.1016/J.Ijrobp.2019.06.1619 |
0.343 |
|
2018 |
Forster N, Warnick R, Takiar V, Pater L, Breneman J. Debulking surgery of pituitary adenoma as a strategy to facilitate definitive stereotactic radiosurgery. Journal of Neuro-Oncology. PMID 29450811 DOI: 10.1007/S11060-018-2801-0 |
0.307 |
|
2018 |
Gulati S, Yaniv B, Palackdharry S, Takiar V, Mierzwa ML, Riaz MK, Morris JC, Xie C, Gutkind JS, Desai PB, Sadraei NH, Wise-Draper TM. A phase I dose-finding study of metformin in combination with concurrent cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma. Journal of Clinical Oncology. 36: 6074-6074. DOI: 10.1200/Jco.2018.36.15_Suppl.6074 |
0.424 |
|
2018 |
Kim E, Palackdharry S, Yaniv B, Mark J, Tang A, Wilson K, Patil Y, Janssen E, Conforti L, Takiar V, Hinrichs B, Wise-Draper TM. Gene expression signature after one dose of neoadjuvant pembrolizumab associated with tumor response in head and neck squamous cell carcinoma (HNSCC). Journal of Clinical Oncology. 36: 6059-6059. DOI: 10.1200/Jco.2018.36.15_Suppl.6059 |
0.337 |
|
2018 |
Wise-Draper TM, Old MO, Worden FP, O'Brien PE, Cohen EEW, Dunlap N, Mierzwa ML, Casper K, Palackdharry S, Hinrichs B, Molinolo A, Takiar V, Mark J, Tang A, Riaz MK, et al. Phase II multi-site investigation of neoadjuvant pembrolizumab and adjuvant concurrent radiation and pembrolizumab with or without cisplatin in resected head and neck squamous cell carcinoma. Journal of Clinical Oncology. 36: 6017-6017. DOI: 10.1200/Jco.2018.36.15_Suppl.6017 |
0.381 |
|
2018 |
Geier N, Bahig H, Phan J, Garden A, Takiar V, Redmond K. (OA29) Low Rate of Contralateral Neck Failure in T1-2N2B TONSIL PATIENTS Treated With Ipsilateral Neck Radiation International Journal of Radiation Oncology Biology Physics. 101. DOI: 10.1016/J.Ijrobp.2018.02.068 |
0.345 |
|
2018 |
Yaniv B, Sadraei NH, Palackdharry S, Takiar V, Wise-Draper T. Metformin Induces Pro-Tumorigenic Cytokines And Natural Killer Cells In Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma International Journal of Radiation Oncology Biology Physics. 100: 1369. DOI: 10.1016/J.Ijrobp.2017.12.161 |
0.38 |
|
2018 |
Palackdharry S, Gillison M, Worden F, Old M, O'brien P, Dunlap NE, Cohen E, Casper K, Mierzwa ML, Morris JC, Sadraei NH, Huth B, Takiar V, Butler R, Mark J, et al. Neoadjuvant Pembrolizumab is Active in Surgically Resected Head and Neck Cancer International Journal of Radiation Oncology Biology Physics. 100: 1365. DOI: 10.1016/J.Ijrobp.2017.12.150 |
0.331 |
|
2018 |
Mierzwa M, Casper K, Redmond KP, Barrett WL, Takiar V, Tang A, Mark J, Wilson K, Wise-Draper T, Sadraei Nh, Huth B. Phase 2 Trial of Adjuvant Concurrent Cetuximab and Radiation for High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck International Journal of Radiation Oncology Biology Physics. 100: 1324. DOI: 10.1016/J.Ijrobp.2017.12.050 |
0.378 |
|
2018 |
Mierzwa M, Biesiada J, Zhang X, Kuhnell D, Redmond KP, Huth B, Takiar V, Wise-Draper T, Sadraei NH, Tang A, Mark J, Casper K, Medvedovic M, Langevin S. Whole-Exome Sequencing of Aggressive Cutaneous Head and Neck Squamous Cell Carcinoma International Journal of Radiation Oncology Biology Physics. 100: 1313-1314. DOI: 10.1016/J.Ijrobp.2017.12.034 |
0.348 |
|
2017 |
Wise-Draper T, Sendilnathan A, Palackdharry S, Pease N, Qualtieri J, Butler R, Sadraei NH, Morris JC, Patil Y, Wilson K, Mark J, Casper K, Takiar V, Lane A, Privette Vinnedge L. Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case-Control Study of Patients with Head and Neck Squamous Cell Carcinoma. Translational Oncology. 11: 168-174. PMID 29289845 DOI: 10.1016/J.Tranon.2017.12.001 |
0.35 |
|
2017 |
Haque S, Riaz MK, Hassan S, Karivedu V, Ying J, Takiar V, Wise-Draper TM. Outcomes in patients with head and neck squamous cell carcinoma (HNSCC) requiring salvage resection after definitive therapy. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E17572 |
0.405 |
|
2017 |
Gulati S, Takiar V, Mark J, Butler R, NeCamp J, Wise-Draper TM. Impact of metformin on survival and mTOR pathway in head and neck cancer patients: An updated analysis. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E17500 |
0.307 |
|
2017 |
Wise-Draper T, Sendilnathan A, Palackdharry S, Pease N, Qualtieri J, Butler R, Sadraei NH, Morris JC, Patil Y, Wilson K, Mark J, Casper K, Takiar V, Lane A, Vinnedge LMP. Abstract 50: Plasma concentrations of the DEK oncogene correlate with pathological variables in a case-control study of patients with HNSCC Clinical Cancer Research. 23: 50-50. DOI: 10.1158/1557-3265.Aacrahns17-50 |
0.328 |
|
2016 |
Tuttle TR, Takiar V, Kumar B, Kumar P, Ben-Jonathan N. Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells. Cancer Letters. PMID 28025101 DOI: 10.1016/J.Canlet.2016.12.020 |
0.348 |
|
2016 |
Sheu T, Garden AS, Fuller CD, Gunn GB, Nguyen T, Beadle BM, Morrison WH, Sio TT, Takiar V, Zafereo M, Rosenthal DI, Frank SJ, Phan J. Reirradiation Utilizing Proton Radiation Therapy May Improve Toxicity Free Survival in Patients With Small-Volume, Recurrent Head And Neck Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E331. PMID 27674401 DOI: 10.1016/J.Ijrobp.2016.06.1461 |
0.411 |
|
2016 |
Damast S, Takiar V, McCarthy S, Higgins SA. Treatment of early stage vaginal cancer with EBRT and MRI-based intracavitary brachytherapy: A retrospective case review. Gynecologic Oncology Reports. 17: 89-92. PMID 27536721 DOI: 10.1016/J.Gore.2016.08.002 |
0.341 |
|
2016 |
Takiar V, Garden AS, Ma D, Morrison WH, Edson M, Zafereo ME, Gunn GB, Fuller CD, Beadle B, Frank SJ, William WN, Kies M, El-Naggar AK, Weber R, Rosenthal DI, et al. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses. International Journal of Radiation Oncology, Biology, Physics. 95: 1117-31. PMID 27354127 DOI: 10.1016/J.Ijrobp.2016.03.015 |
0.43 |
|
2016 |
Phan J, Sio TT, Nguyen TP, Takiar V, Gunn GB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Beadle B, Ma D, Zafereo ME, Hutcheson KA, Kupferman ME, William WN, et al. Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses. International Journal of Radiation Oncology, Biology, Physics. PMID 27325480 DOI: 10.1016/J.Ijrobp.2016.03.053 |
0.372 |
|
2016 |
Edson MA, Garden AS, Takiar V, Glisson BS, Fuller CD, Gunn GB, Beadle BM, Morrison WH, Frank SJ, Shah SJ, Tao R, William WN, Weber RS, Rosenthal DI, Phan J. Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy. Head & Neck. PMID 26920665 DOI: 10.1002/Hed.24387 |
0.374 |
|
2016 |
Wise-Draper TM, Takiar V, Mierzwa ML, Huth BJ, Redmond KP, Barrett W, Qualtieri J, Xie C, Morris JC, Gutkind JS, Sadraei NH. A phase I study of metformin in combination with cisplatin and radiation in locally advanced head and neck squamous cell carcinoma. Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.Tps6109 |
0.403 |
|
2016 |
Havard K, Elson JK, Kharofa JR, Takiar V. Pain Reporting by Head and Neck Cancer Patients: Quality of Life Outcomes and Analyses Using EORTC QLQ-C30 Data International Journal of Radiation Oncology Biology Physics. 96. DOI: 10.1016/J.Ijrobp.2016.06.1962 |
0.3 |
|
2016 |
Phan J, Garden A, Gunn G, Fuller C, Shah S, Frank S, Beadle B, Morrison W, Garcia S, Wang H, Wang C, Tung S, Edson M, Takiar V, Brown P, et al. Linear Accelerator–Based Stereotactic Ablative Radiation Therapy Reirradiation for Unresectable Recurrent Head and Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 94: 932-933. DOI: 10.1016/J.Ijrobp.2015.12.248 |
0.394 |
|
2016 |
Martin GV, Takiar V, Phan J. Patterns of Failure After Salvage Surgery and Intensity Modulated Radiation Therapy Reirradiation for Recurrent Head and Neck Squamous Cell Carcinoma International Journal of Radiation Oncology Biology Physics. 94: 931. DOI: 10.1016/J.Ijrobp.2015.12.244 |
0.4 |
|
2016 |
Takiar V, Quinlan-Davidson S, Tung S, Garden AS, Morrison WH, Rosenthal DI, Gunn GB, Fuller CD, Beadle BM, Wang H, Wang C, Phan J. A Comparison of Split-Field and Whole-Field Intensity Modulated Radiation Therapy and Volumetric Modulated Arc Therapy for Laryngeal Sparing in Oropharynx Cancer International Journal of Radiation Oncology Biology Physics. 94: 894-895. DOI: 10.1016/J.Ijrobp.2015.12.095 |
0.313 |
|
2015 |
Takiar V, Ma D, Garden AS, Li J, Rosenthal DI, Beadle BM, Frank SJ, Fuller CD, Gunn GB, Morrison WH, Hutcheson K, El-Naggar AK, Gold KA, Kupferman ME, Phan J. Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapy. Head & Neck. PMID 25994561 DOI: 10.1002/Hed.24128 |
0.378 |
|
2015 |
Tao R, Ma D, Takiar V, Frank SJ, Fuller CD, Gunn GB, Beadle BM, Morrison WH, Rosenthal DI, Edson MA, Esmaeli B, Kupferman ME, Hanna EY, Garden AS, Phan J. Orbital carcinomas treated with adjuvant intensity-modulated radiation therapy. Head & Neck. PMID 25782700 DOI: 10.1002/Hed.24044 |
0.384 |
|
2015 |
Edson MA, Garden AS, Takiar V, Gunn GB, Fuller CD, Rosenthal DI, Kies MS, Phan J. Use of chemotherapy with IMRT reirradiation: MDACC experience. Journal of Clinical Oncology. 33: 6065-6065. DOI: 10.1200/Jco.2015.33.15_Suppl.6065 |
0.391 |
|
2015 |
Martin G, Takiar V, Beadle B, Frank S, Fuller C, Garden A, Gunn G, Morrison W, Rosenthal D, Skinner H, Zafereo M, Phan J. Patterns of Failure for Recurrent Head and Neck Squamous Cell Carcinoma Treated With Salvage Surgery and Reirradiation using IMRT International Journal of Radiation Oncology*Biology*Physics. 93: E350. DOI: 10.1016/J.Ijrobp.2015.07.1439 |
0.37 |
|
2014 |
Takiar V, Akay CL, Stauder MC, Tereffe W, Alvarez RH, Hoffman KE, Perkins GH, Strom EA, Buchholz TA, Ueno NT, Babiera G, Woodward WA. Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation. Springerplus. 3: 166. PMID 24711988 DOI: 10.1186/2193-1801-3-166 |
0.384 |
|
2014 |
Hoffman KE, Voong KR, Pugh TJ, Skinner H, Levy LB, Takiar V, Choi S, Du W, Frank SJ, Johnson J, Kanke J, Kudchadker RJ, Lee AK, Mahmood U, McGuire SE, et al. Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial. International Journal of Radiation Oncology, Biology, Physics. 88: 1074-84. PMID 24661661 DOI: 10.1016/J.Ijrobp.2014.01.015 |
0.314 |
|
2014 |
Woodward WA, Koay E, Takiar V. Radiation therapy for inflammatory breast cancer: technical considerations and diverse clinical scenarios Breast Cancer Management. 3: 43-52. DOI: 10.2217/Bmt.13.68 |
0.354 |
|
2013 |
Fontanilla HP, Klopp AH, Lindberg ME, Jhingran A, Kelly P, Takiar V, Iyer RB, Levenback CF, Zhang Y, Dong L, Eifel PJ. Anatomic distribution of [(18)F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Practical Radiation Oncology. 3: 45-53. PMID 24674263 DOI: 10.1016/J.Prro.2012.02.003 |
0.316 |
|
2013 |
Takiar V, Strom EA, Baumann DP, Meric-Bernstam F, Alvarez RH, Gonzalez-Angulo AM. Locoregional interaction of ixabepilone (Ixempra) after breast cancer radiation Oncologist. 18: 265-270. PMID 23404814 DOI: 10.1634/Theoncologist.2012-0348 |
0.361 |
|
2013 |
Takiar V, Ma D, Rosenthal DI, Ang KK, Beadle B, Frank SJ, Fuller CD, Gunn GB, Morrison WH, William WN, Pytynia KB, Garden AS, Phan J. OP064: Reirradiation of head and neck cancers with IMRT: Updated outcomes and analysis Oral Oncology. 49. DOI: 10.1016/J.Oraloncology.2013.03.072 |
0.394 |
|
2013 |
Takiar V, Rosenthal DI, Ang K, Beadle BM, Frank SJ, Fuller CD, Gunn B, Morrison WH, Garden AS, Phan J. Reirradiation of Head-and-Neck Cancers: An MD Anderson Update International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1230 |
0.34 |
|
2012 |
Takiar V, Mistry K, Carmosino M, Schaeren-Wiemers N, Caplan MJ. VIP17/MAL expression modulates epithelial cyst formation and ciliogenesis. American Journal of Physiology. Cell Physiology. 303: C862-71. PMID 22895261 DOI: 10.1152/Ajpcell.00338.2011 |
0.513 |
|
2011 |
Takiar V, Nishio S, Seo-Mayer P, King JD, Li H, Zhang L, Karihaloo A, Hallows KR, Somlo S, Caplan MJ. Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proceedings of the National Academy of Sciences of the United States of America. 108: 2462-7. PMID 21262823 DOI: 10.1073/Pnas.1011498108 |
0.506 |
|
2011 |
Takiar V, Caplan MJ. Polycystic kidney disease: pathogenesis and potential therapies. Biochimica Et Biophysica Acta. 1812: 1337-43. PMID 21146605 DOI: 10.1016/J.Bbadis.2010.11.014 |
0.525 |
|
2010 |
Takiar V, Caplan MJ. Telling kidneys to cease and decyst. Nature Medicine. 16: 751-2. PMID 20613749 DOI: 10.1038/Nm0710-751 |
0.511 |
|
Show low-probability matches. |